Mechanisms responsible for interindividual variability of bioavailability of therapeutic compounds in patients with acute renal failure and related homeostasis perturbation
急性肾衰竭患者治疗化合物生物利用度个体差异及相关稳态扰动的机制
基本信息
- 批准号:18590141
- 负责人:
- 金额:$ 2.45万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mechanisms responsible for blood concentration of therapeutic compounds being considerably altered in acute renal failure were investigated. It was shown that protein unbound fraction of a representative compound quinidine is decreased in acute renal failure, whereas those of acid compounds, such as tolbutamide, has been known to be increased. The decreased unbound fraction of quinidine seems to be related to the fact that the hepatic production of alpha-1 acid glycoprotein (AGP) increases in acute renal failure, resulting in an increase in the plasma AGP concentration. In addition, we revealed that lithium disposition to cerebrospinal fluid (CSF) decreases when the kidney function is impaired, and that the choroid plexial expression of NKCC1 increases in acute renal failure. Therefore, it is plausible that the decreased lithium disposition to CSF is caused by an increased lithium efflux from CSF due to an increased NKCC1 expression in the choroid plexus. We also found that the transporter-mediated intestinal absorption of cephalexin is suppressed by stimulating a cation channel TRPV1 expressed on afferent neurons innervating gastro-intestinal tract. As afferent neurons seem to play an important role in regulating intestinal drug absorption and its alternation in acute renal failure, future study should be conducted to clarify this.
研究了急性肾衰竭时治疗化合物的血液浓度发生显着改变的机制。结果表明,代表性化合物奎尼丁的蛋白质未结合部分在急性肾衰竭中减少,而酸性化合物(例如甲苯磺丁脲)的蛋白质未结合部分则增加。奎尼丁未结合部分的减少似乎与急性肾功能衰竭时肝脏产生的α-1酸性糖蛋白(AGP)增加,导致血浆AGP浓度增加有关。此外,我们发现,当肾功能受损时,锂在脑脊液(CSF)中的分布会减少,并且在急性肾功能衰竭时,NKCC1的脉络丛表达会增加。因此,脑脊液锂分布减少可能是由于脉络丛中 NKCC1 表达增加导致锂从脑脊液流出增加所致。我们还发现,通过刺激在支配胃肠道的传入神经元上表达的阳离子通道TRPV1,可以抑制转运蛋白介导的头孢氨苄肠道吸收。由于传入神经元似乎在调节肠道药物吸收及其在急性肾功能衰竭中的变化中发挥着重要作用,因此未来的研究应该阐明这一点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interindividual variability of unbound fraction of valproic acid in epileptic neonates and infants
癫痫新生儿和婴儿中丙戊酸未结合部分的个体差异
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Nanase;Ishikawa;et. al.
- 通讯作者:et. al.
Effects of capsaicin on intestinal cephalexin absorption in rats
辣椒素对大鼠小肠头孢氨苄吸收的影响
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yukiko Komori;et. al.
- 通讯作者:et. al.
Effects of sulfonamides on tolbutamide pharmacokinetics in rats receiving peritoneal dialysis
磺胺类药物对腹膜透析大鼠甲苯磺丁脲药代动力学的影响
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Takashi;Makita;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AIBA Tetsuya其他文献
AIBA Tetsuya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AIBA Tetsuya', 18)}}的其他基金
Understanding mechanisms underlying an increased sensitivity of central nervous system to therapeutic compounds with decreased renal function for dose optimization and individualizing treatment
了解中枢神经系统对肾功能下降的治疗化合物敏感性增加的机制,以优化剂量和个体化治疗
- 批准号:
21590159 - 财政年份:2009
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Pharmacokinetics-Based DNA-Encoded Library Screening
基于药代动力学的 DNA 编码文库筛选
- 批准号:
10644211 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Clinical pharmacokinetics and pharmacodynamics of antiseizure medications in special populations with epilepsy
抗癫痫药物在癫痫特殊人群中的临床药代动力学和药效学
- 批准号:
23K06250 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Clinical investigation on factors affecting pharmacokinetics for the individual dosing design of orexin receptor antagonists
食欲素受体拮抗剂个体化给药设计影响药代动力学因素的临床研究
- 批准号:
23K06237 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inner ear pharmacokinetics and development of drug delivery systems targeting the inner ear barrier mechanism
内耳药代动力学和针对内耳屏障机制的药物递送系统的开发
- 批准号:
23K08952 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cavity and Granuloma Oriented Inflammation and Tissue Pharmacokinetics in Pulmonary Tuberculosis (COOK TB)
肺结核 (COOK TB) 中空洞和肉芽肿导向的炎症和组织药代动力学
- 批准号:
10568147 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
A STUDY TO ASSESS EFFICACY, SAFTETY AND PHARMACOKINETICS OF EYU688 IN HEALTHY PARTICIPANTS CHALLENGED WITH DENGUE SEROTYPE 2
评估 EYU688 对患有登革热血清型 2 的健康参与者的功效、安全性和药代动力学的研究
- 批准号:
10925568 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
EPCTU: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Tuberculosis
EPCTU:一项评估结核病治疗药物的药代动力学和安全性的研究
- 批准号:
10912971 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:
Formulation and pharmacokinetics of subcutaneous administration of deferiprone for prevention of chronic heart failure following hemorrhagic myocardial infarction.
皮下注射去铁酮预防出血性心肌梗死后慢性心力衰竭的配方和药代动力学。
- 批准号:
10700370 - 财政年份:2023
- 资助金额:
$ 2.45万 - 项目类别:














{{item.name}}会员




